From: Chapter 10, Community-based pharmacists
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Outcomes | No of Participants (studies) Follow up | Quality of the evidence (GRADE) | Relative effect (95% CI) | Anticipated absolute effects | |
---|---|---|---|---|---|
Risk with Control | Risk difference with Community pharmacist @ pharmacy versus usual care (95% CI) | ||||
Mortality |
2989 (6 studies) 6 months |
⊕⊝⊝⊝ due to risk of bias, inconsistency, imprecision | RR 0.69 (0.46 to 1.02) | Moderate | |
32 per 1000 |
10 fewer per 1000 (from 17 fewer to 1 more) | ||||
ED presentations |
2413 (7 studies) 3 months |
⊕⊝⊝⊝ due to risk of bias, imprecision | RR 0.63 (0.53 to 0.76) | Moderate | |
93 per 1000 |
34 fewer per 1000 (from 22 fewer to 44 fewer) | ||||
ED presentations |
314 (1 study) 12 months |
⊕⊕⊝⊝ LOWa due to risk of bias |
The mean ED presentations in the control groups was 2.68 days |
The mean ED presentations in the intervention groups was 0.52 lower (1.43 lower to 0.39 higher) | |
Hospital admissions |
1267 (7 studies) 3 months |
⊕⊝⊝⊝ due to risk of bias, inconsistency, imprecision | RR 0.92 (0.56 to 1.49) | Moderate | |
93 per 1000 |
7 fewer per 1000 (from 41 fewer to 46 more) | ||||
Mean number of hospitalisations |
1612 (2 study) 6-12 months |
⊕⊕⊕⊝ MODERATEa due to risk of bias |
The mean number of hospitalisations in the control groups was 0.08 admissions |
The mean number of hospitalisations in the intervention groups was 0.02 lower (0.05 lower to 0.1 higher) | |
GP visits |
330 (2 studies) 2-3 months |
⊕⊝⊝⊝ due to risk of bias, inconsistency, imprecision | RR 0.6 (0.17 to 2.06) | Moderate | |
797 per 1000 |
319 fewer per 1000 (from 662 fewer to 845 more) |
Downgraded by 1 increment if the majority of the evidence was at high risk of bias, and downgraded by 2 increments if the majority of the evidence was at very high risk of bias.
Downgraded by 1 or 2 increments because: the point estimate varies widely across studies, unexplained by subgroup analysis.
Downgraded by 1 increment if the confidence interval crossed 1 MID or by 2 increments if the confidence interval crossed both MIDs.
From: Chapter 10, Community-based pharmacists
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.